Oscar Health annual stock-based compensation
2019
2020
2021
2022
2023
2024
2025
Oscar Health Stock-Based Compensation Growth & History (OSCR)
Oscar Health's stock-based compensation was $87.7M for fiscal 2025.
View full Oscar Health company overviewOscar Health annual stock-based compensation history
| Fiscal year | Period ended | Stock-based compensation | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $87.7M | −$22.2M | −20.19% |
| 2024 | 2024-12-31 | $109.8M | −$49.9M | −31.22% |
| 2023 | 2023-12-31 | $159.7M | $47.4M | +42.16% |
| 2022 | 2022-12-31 | $112.3M | $26.0M | +30.17% |
| 2021 | 2021-12-31 | $86.3M | $50.4M | +140.59% |
| 2020 | 2020-12-31 | $35.9M | $2.3M | +6.89% |
| 2019 | 2019-12-31 | $33.6M | — | — |
Oscar Health quarterly stock-based compensation
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Stock-based compensation | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $20.7M | −$3.5M | −14.33% |
| Q1 2026 | 2026-03-31 | $16.0M | −$9.0M | −36.06% |
| Q4 2025 | 2025-12-31 | $18.1M | −$7.8M | −30.05% |
| Q3 2025 | 2025-09-30 | $20.5M | −$8.8M | −30.11% |
| Q2 2025 | 2025-06-30 | $24.1M | −$4.6M | −16.03% |
| Q1 2025 | 2025-03-31 | $25.0M | −$970,000 | −3.74% |
| Q4 2024 | 2024-12-31 | $25.9M | −$287,000 | −1.10% |
| Q3 2024 | 2024-09-30 | $29.3M | $543,000 | +1.89% |
| Q2 2024 | 2024-06-30 | $28.7M | −$4.6M | −13.72% |
| Q1 2024 | 2024-03-31 | $25.9M | −$45.5M | −63.71% |
| Q4 2023 | 2023-12-31 | $26.1M | −$2.9M | −10.13% |
| Q3 2023 | 2023-09-30 | $28.8M | $208,000 | +0.73% |
| Q2 2023 | 2023-06-30 | $33.3M | $6.3M | +23.30% |
| Q1 2023 | 2023-03-31 | $71.5M | $43.8M | +158.19% |
| Q4 2022 | 2022-12-31 | $29.1M | $820,000 | +2.90% |
| Q3 2022 | 2022-09-30 | $28.6M | $7.9M | +38.37% |
| Q2 2022 | 2022-06-30 | $27.0M | $8.7M | +47.71% |
| Q1 2022 | 2022-03-31 | $27.7M | $8.6M | +44.86% |
| Q4 2021 | 2021-12-31 | $28.3M | $14.4M | +103.59% |
| Q3 2021 | 2021-09-30 | $20.6M | $13.4M | +183.24% |
| Q2 2021 | 2021-06-30 | $18.3M | $11.7M | +176.82% |
| Q1 2021 | 2021-03-31 | $19.1M | $11.0M | +136.10% |
| Q4 2020 | 2020-12-31 | $13.9M | — | — |
| Q3 2020 | 2020-09-30 | $7.3M | — | — |
| Q2 2020 | 2020-06-30 | $6.6M | — | — |
| Q1 2020 | 2020-03-31 | $8.1M | — | — |
Oscar Health stock-based compensation trends
Over the last five fiscal years, Oscar Health's stock-based compensation increased from $35.9M to $87.7M, a change of $51.8M. The latest reported quarter, Q2 2026, shows $20.7M.
About the metric
What stock-based compensation means
Stock-based compensation is the expense associated with equity awards such as restricted stock and employee options. It is a non-cash expense when recognized, but it can dilute existing shareholders unless offset by share repurchases.
Calculation and source
SEC-reported stock-based compensation
TickerStat standardizes share-based compensation reported in company SEC filings. The history shows recognized compensation expense or its cash-flow-statement adjustment, not the grant-date value of new awards or a forecast of future dilution. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Oscar Health source filings ↗